Sf. Jencks et al., Quality of medical care delivered to Medicare beneficiaries - A profile atstate and national levels, J AM MED A, 284(13), 2000, pp. 1670-1676
Citations number
14
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context Despite condition-specific and managed care-specific reports, no sy
stematic program has been developed for monitoring the quality of medical c
are provided to Medicare beneficiaries.
Objective To create a monitoring system for a range of measures of clinical
performance that supports quality improvement and provides repeated, relia
ble estimates at the national and state levels for fee-for-service (FFS) Me
dicare beneficiaries.
Design, setting, and Participants National study of repeated, cross-section
al observational data collected in 1997-1999 on all Medicare FFS beneficiar
ies or on a representative sample of beneficiaries with a particular condit
ion. Data were collected using medical record abstraction for inpatient car
e, analysis of Medicare claims for some ambulatory services, and surveys fo
r immunization rates. Separate samples were drawn for each topic for each s
tate.
Main Outcome Measures Beneficiary patients' receipt of 24 process-of-care m
easures related to primary prevention, secondary prevention, or treatment o
f 6 medical conditions (acute myocardial infarction, breast cancer, diabete
s mellitus, heart failure, pneumonia, and stroke) for which there is strong
scientific evidence and professional consensus that the process of care ei
ther directly improves outcomes or is a necessary step in a chain of care t
hat does so.
Results Across all states for all measures, the percentage of patients rece
iving appropriate care in the median state ranged from a high of 95% (avoid
ance of sublingual nifedipine for patients with acute stroke) to a low of 1
1% (patients with pneumonia screened for pneumococcal immunization status b
efore discharge). The median performance on an indicator is 69% (patients d
ischarged with heart-failure diagnosis who received angiotensin-converting
enzyme inhibitors; diabetic patients having an eye examination in the last
2 years). Some states (particularly less populous states and those in the N
ortheast) consistently ranked high in relative performance while others (pa
rticularly more populous states and those in the Southeast) consistently ra
nked low.
Conclusions It is possible to assemble information on a diverse set of clin
ical performance measures that represent performance on the range of servic
es in a health insurance program. These findings indicate substantial oppor
tunities to improve the care delivered to Medicare beneficiaries and urgent
ly invite a partnership among practitioners, hospitals, health plans, and p
urchasers to achieve that improvement.